These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35465814)

  • 1. Molecular imaging in management of colorectal metastases by the interventional oncologist.
    Hunt S; Zandifar A; Alavi A
    Int J Hyperthermia; 2022; 39(1):675-681. PubMed ID: 35465814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging using positron emission tomography in colorectal cancer.
    Lin M
    Discov Med; 2011 May; 11(60):435-47. PubMed ID: 21616042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
    Wiering B; Vogel WV; Ruers TJ; Oyen WJ
    Dig Surg; 2008; 25(6):413-20. PubMed ID: 19212113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review.
    Chowdhury FU; Shah N; Scarsbrook AF; Bradley KM
    Postgrad Med J; 2010 Mar; 86(1013):174-82. PubMed ID: 20237012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography and colorectal cancer.
    Lin M; Wong K; Ng WL; Shon IH; Morgan M
    Crit Rev Oncol Hematol; 2011 Jan; 77(1):30-47. PubMed ID: 20619671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review.
    de Geus-Oei LF; Vriens D; van Laarhoven HW; van der Graaf WT; Oyen WJ
    J Nucl Med; 2009 May; 50 Suppl 1():43S-54S. PubMed ID: 19403879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
    Laurens ST; Oyen WJ
    PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
    Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
    Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer.
    Strasberg SM; Dehdashti F
    J Surg Oncol; 2010 Dec; 102(8):955-9. PubMed ID: 21165998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases.
    Nielsen K; Scheffer HJ; Pieters IC; van Tilborg AA; van Waesberghe JH; Oprea-Lager DE; Meijerink MR; Kazemier G; Hoekstra OS; Schreurs HW; Sietses C; Meijer S; Comans EF; van den Tol PM
    BMC Med Imaging; 2014 Aug; 14():27. PubMed ID: 25103913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
    Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ
    Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET-scan in colorectal cancer.
    Lonneux M
    Acta Chir Belg; 2005 Aug; 105(4):333-7. PubMed ID: 16184712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-PET in colorectal cancer.
    de Geus-Oei LF; Ruers TJ; Punt CJ; Leer JW; Corstens FH; Oyen WJ
    Cancer Imaging; 2006 Oct; 6(Spec No A):S71-81. PubMed ID: 17114081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases.
    Zubeldia JM; Bednarczyk EM; Baker JG; Nabi HA
    Cancer Biother Radiopharm; 2005 Aug; 20(4):450-6. PubMed ID: 16114993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [F-18 fluorodeoxyglucose positron emission tomography in colorectal carcinoma].
    Jörg L; Langsteger W
    Wien Med Wochenschr; 2002; 152(11-12):276-9. PubMed ID: 12138655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal tract malignancies and positron emission tomography: an overview.
    Esteves FP; Schuster DM; Halkar RK
    Semin Nucl Med; 2006 Apr; 36(2):169-81. PubMed ID: 16517238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [18F-fluorodeoxyglucose positron emission tomography in colorectal cancer: value in primary staging and follow-up].
    Jörg L; Heinisch M; Rechberger E; Kurz F; Klug R; Aufschnaiter M; Hammer J; Langsteger W
    Acta Med Austriaca; 2002; 29(5):176-9. PubMed ID: 12506769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer.
    Pelosi E; Deandreis D
    Eur J Surg Oncol; 2007 Feb; 33(1):1-6. PubMed ID: 17126522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
    Briggs RH; Chowdhury FU; Lodge JP; Scarsbrook AF
    Clin Radiol; 2011 Dec; 66(12):1167-74. PubMed ID: 21867996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET and PET-CT for evaluation of colorectal carcinoma.
    Delbeke D; Martin WH
    Semin Nucl Med; 2004 Jul; 34(3):209-23. PubMed ID: 15202102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.